Implementation and evaluation of a pragmatic community streptococcal treatment programme to improve rheumatic heart disease primary prevention in Uganda. [PDF]
Ndagire E +18 more
europepmc +1 more source
Graphical abstract summarizing the multifactorial pathogenesis of rheumatoid arthritis (RA) and the therapeutic potential of mesenchymal stromal cell (MSC) therapy. MSCs provide promising benefits through their immunomodulatory properties, low immunogenicity, ability to promote tissue repair, and multi‐lineage differentiation, presenting a potential ...
Yingjia Chen +6 more
wiley +1 more source
Machine learning for classification of advanced rheumatic heart disease using electrocardiogram in cardiology ward. [PDF]
Chuma AT +5 more
europepmc +1 more source
Stakeholders Want a Menu of Choices: Findings from a Consultation Workshop on Improving Access to Secondary Prophylaxis of Rheumatic Fever and Rheumatic Heart Disease. [PDF]
Hla TK +6 more
europepmc +1 more source
This large‐scale retrospective study of 5778 primary Sjögren's disease (SjD) patients, stratified by diagnostic age, defines a distinct clinical and immunological profile for early‐diagnosed (<45 years) disease. We identified early diagnosis as an independent risk factor for hypergammaglobulinemia and interstitial lung disease, underpinned by a ...
Yuan Ning +7 more
wiley +1 more source
The economic burden of rheumatic heart disease in the Eastern Mediterranean Region. [PDF]
Elmusharaf K +8 more
europepmc +1 more source
Graphical Abstract The evolving role of regulatory T cells in primary Sjögren's disease pathogenesis and the promise of Treg‐based therapies. Abstract Sjögren's disease (SjD) is a chronic systemic autoimmune disorder characterised by exocrine gland dysfunction and diverse systemic manifestations.
Gagan Urs +5 more
wiley +1 more source
Rheumatic Heart Disease: Global Failure in Tackling a Common Killer. [PDF]
Manuel V, Mocumbi AO, Zühlke L.
europepmc +1 more source
Patient‐reported outcomes (PROs) were compared among rheumatoid arthritis patients who maintained low disease activity or remission for at least 6 months based on the disease‐modifying antirheumatic drug (DMARD)administered. Even with comparable disease activity, methotrexate (MTX) group, biological/targeted synthetic DMARDs (b/tsDMARDs), particularly ...
Masafumi Sugiyama +4 more
wiley +1 more source
Prevalence of Rheumatic Heart Disease Among School-Aged Children in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis. [PDF]
Okorie MA +11 more
europepmc +1 more source

